Live Event Content · EUPSA - Circular RNA profiles isolated from amniotic fluidscan distinguish between CDH survivors and non-survivers - Richard Wagner
Follow
Video9 min·Published May 2022Older

EUPSA - Circular RNA profiles isolated from amniotic fluidscan distinguish between CDH survivors and non-survivers - Richard Wagner

With Dr. Richard Wagner · hosted by Dr. Udo Rohle · Live Event Content
Try
Intelligent Search· scoped to CDH · not medical adviceSearch the whole library →

More about CDH

same diagnosis

More from Dr. Wagner

same expert · first-hand onlyDive deeper → Dr. Richard Wagner
Only a few other public items share this expert — go deeper there →

More from Live Event Content

same institutionDive deeper → Live Event Content
What the experts said16 expert statements
Prenatal diagnosis and prognostication of CDH cases relies currently only on imaging modalities, with sensitivity for CDH cases around 70%.
ClinicalRichard Wagner
Circular RNAs are an RNA species with a circular shape that is highly stable in biofluids and has potential as biomarkers in several human disease contexts.
ClinicalRichard Wagner
Circular RNA profiles are significantly altered between CDH and control fetal lungs at two different developmental time points.
ClinicalRichard Wagner
The microarray profiling detected approximately 12,000 circular RNAs in fetal lung tissue samples.
ClinicalRichard Wagner
An algorithm could successfully cluster CDH lungs and control lungs into two separate groups based on circular RNA profiles at both developmental time points investigated.
ClinicalRichard Wagner
Amniotic fluid samples were obtained from CDH cases undergoing fetal tracheal occlusion.
ClinicalRichard Wagner
At the time point of amniotic fluid sampling, observed over expected lung to head ratio was similar between survivors and non-survivors.
ClinicalRichard Wagner
Gestational age, liver herniation, and birth weight did not differ between CDH survivors and non-survivors at the time of amniotic fluid sampling.
ClinicalRichard Wagner
Circular RNA profiles isolated from amniotic fluid samples can distinguish between CDH survivors and non-survivors, indicating prognostic value superior to current imaging modalities.
ClinicalRichard Wagner
The research goal is to validate these biomarkers in amniotic fluids in a larger and independent clinical cohort and define 2 to 3 markers that can predict outcomes in CDH cases.
OpinionRichard Wagner
The team plans to test whether circular RNA markers can be isolated from maternal blood samples instead of amniotic fluid.
OpinionRichard Wagner
The COVID pandemic impacted the study by limiting patient recruitment and CDH case enrollment.
ClinicalRichard Wagner
The initial study was a screening experiment that profiled all detectable circular RNAs in samples.
ClinicalRichard Wagner
The team received funding from the Canadian Institutes of Health Research for a multi-center study to increase sample size and validate findings.
ClinicalRichard Wagner
The study is not currently powered to stratify cases of syndromic CDH versus non-syndromic CDH or different severity levels.
ClinicalRichard Wagner
Based on prior work with circular RNAs in CDH lungs, the researchers believe they have a disease-specific marker.
OpinionRichard Wagner